Anti-cancer agents in medicinal chemistry

(ISSN: 1871-5206, 1875-5992)

Anti-cancer agents in medicinal chemistry's Latest Table of Contents

2016 - 16 (4)

  • MicroRNA-183 Functions As an Oncogene by Regulating PDCD4 in Gastric Cancer. 
  • Editorial: Special Thematic Issuue: Development of Biomarkers in Tumors of Digestive System Part I. 
  • Differential Gene Expression of BRCA1,ERBB2 and TP53 biomarkers between Human Breast Tissue and Peripheral Blood Samples of Breast Cancer. 
  • MicroRNA-31 inhibits lung adenocarcinoma stem-like cells via down-regulation of MET-PI3K-Akt signaling pathway. 
  • Recent Developments on 1,2,4-Triazole Nucleus in Anticancer Compounds: A Review. 
  • Sodium Selenite Decreased HDAC Activity, Cell Proliferation and Induced Apoptosis in Three Human Glioblastoma Cells. 
  • miR-203 suppresses the proliferation and metastasis of hepatocellular carcinoma by targeting oncogene ADAM9 and oncogenic long non-coding RNA HULC. 
  • Serum miR-372 is a Diagnostic and Prognostic Biomarker in Patients with Early Colorectal Cancer. 
  • SCYL1-BP1 affects cell cycle arrest in human hepatocellular carcinoma cells via Cyclin F and RRM2. 
  • Prognostic Value and Clinicopathological Differences of Bmi1 in Gastric Cancer: A Meta-analysis. 
  • Pseudogene PTENP1 Suppresses Gastric Cancer Progression by Modulating PTEN. 
  • miRNA-101 Suppresses Epithelial-to-Mesenchymal Transition by Targeting HMGA2 in Pancreatic Cancer Cells. 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.